News
API and Eli Lilly launch nationwide CME programme to strengthen obesity care among indian physicians
The Obesity Gurukul initiative will train over 20,000 healthcare professionals across India through a hybrid education model ...
The initiative will provide practical insights into understanding of obesity pathophysiology and its management.
"Obesity is a complex, chronic condition that requires more than just treatment--it demands continuous medical education, empathy, and coordinated action across the healthcare ecosystem," said Dr.
Lilly partners with API to launch ‘Obesity Gurukul’, a flagship continuing medical education program
Lilly partners with API to launch ‘Obesity Gurukul’, a flagship continuing medical education program: Our Bureau, Bengaluru Monday, July 14, 2025, 15:20 Hrs [IST] Eli Lilly an ...
Referrals to an obesity clinic almost doubled after a novel educational intervention addressed negative attitudes and suboptimal practice patterns.
A collection of top researchers have made the case for a new way to understand and diagnose obesity beyond using BMI as a measure.
2d
Stockhead on MSNScoPo’s Powerplays: CSL leads a 5pc ASX health stocks rallyMorgans healthcare and life sciences expert Iain Wilkie fills in for Scott Power this week, covering what the health movers ...
Business Insider spoke to Eli Lilly's new president of cardiometabolic health, who shared the company's aggressive incretin ...
An obesity drug from Hengrui Pharma and Kailera Therapeutics succeeded in a late-stage trial in China, while Anne Wojcicki’s ...
The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should ...
An obesity drug from China helped patients lose a lot of weight in a late-stage clinical trial, making it a prospective new challenger to blockbusters from Novo Nordisk A/S and Eli Lilly & Co.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results